14-78243471-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001330195.2(NRXN3):āc.378T>Cā(p.Asp126=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.211 in 1,583,006 control chromosomes in the GnomAD database, including 36,913 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.17 ( 2690 hom., cov: 32)
Exomes š: 0.22 ( 34223 hom. )
Consequence
NRXN3
NM_001330195.2 synonymous
NM_001330195.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.70
Genes affected
NRXN3 (HGNC:8010): (neurexin 3) This gene encodes a member of a family of proteins that function in the nervous system as receptors and cell adhesion molecules. Extensive alternative splicing and the use of alternative promoters results in multiple transcript variants and protein isoforms for this gene, but the full-length nature of many of these variants has not been determined. Transcripts that initiate from an upstream promoter encode alpha isoforms, which contain epidermal growth factor-like (EGF-like) sequences and laminin G domains. Transcripts initiating from the downstream promoter encode beta isoforms, which lack EGF-like sequences. Genetic variation at this locus has been associated with a range of behavioral phenotypes, including alcohol dependence and autism spectrum disorder. [provided by RefSeq, Dec 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 14-78243471-T-C is Benign according to our data. Variant chr14-78243471-T-C is described in ClinVar as [Benign]. Clinvar id is 674092.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.7 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.223 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NRXN3 | NM_001330195.2 | c.378T>C | p.Asp126= | synonymous_variant | 2/21 | ENST00000335750.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NRXN3 | ENST00000335750.7 | c.378T>C | p.Asp126= | synonymous_variant | 2/21 | 5 | NM_001330195.2 | P1 | |
NRXN3 | ENST00000634499.2 | c.378T>C | p.Asp126= | synonymous_variant | 2/22 | 5 | |||
NRXN3 | ENST00000554738.5 | c.378T>C | p.Asp126= | synonymous_variant | 1/20 | 5 |
Frequencies
GnomAD3 genomes AF: 0.174 AC: 26519AN: 152102Hom.: 2688 Cov.: 32
GnomAD3 genomes
AF:
AC:
26519
AN:
152102
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.195 AC: 39594AN: 202706Hom.: 4069 AF XY: 0.200 AC XY: 22426AN XY: 111866
GnomAD3 exomes
AF:
AC:
39594
AN:
202706
Hom.:
AF XY:
AC XY:
22426
AN XY:
111866
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.215 AC: 308096AN: 1430788Hom.: 34223 Cov.: 33 AF XY: 0.216 AC XY: 153638AN XY: 710436
GnomAD4 exome
AF:
AC:
308096
AN:
1430788
Hom.:
Cov.:
33
AF XY:
AC XY:
153638
AN XY:
710436
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.174 AC: 26530AN: 152218Hom.: 2690 Cov.: 32 AF XY: 0.174 AC XY: 12984AN XY: 74418
GnomAD4 genome
AF:
AC:
26530
AN:
152218
Hom.:
Cov.:
32
AF XY:
AC XY:
12984
AN XY:
74418
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
425
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 19, 2018 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at